TrAMPoline Pharma
Phase 1TrAMPoline Pharma is a cellular immunotherapy company that is developing personalized (autologous) therapies for solid tumor cancers. Our lead therapeutic candidate, MightyTIL™ is a gene engineered tumor infiltrating lymphocyte (TIL) targeting orphan cancer indications (sarcoma, head and neck cancer) and melanoma. MightyTIL has demonstrated significantly enhanced anti-tumor activity in multiple animal tumor models as compared with conventional unmodified TIL.
About
TrAMPoline Pharma is a cellular immunotherapy company that is developing personalized (autologous) therapies for solid tumor cancers. Our lead therapeutic candidate, MightyTIL™ is a gene engineered tumor infiltrating lymphocyte (TIL) targeting orphan cancer indications (sarcoma, head and neck cancer) and melanoma. MightyTIL has demonstrated significantly enhanced anti-tumor activity in multiple animal tumor models as compared with conventional unmodified TIL.
Company Info
Contact
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile